# Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus (MSSA/MRSA) - Point-of-care-testing (POCT) in Clinical Decision Making

> **NCT03220386** · NA · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 1000 (estimated)

## Conditions studied

- Staphylococcus Aureus

## Interventions

- **OTHER:** Decolonization by nasal Octinidin treatment and skin washings

## Key facts

- **NCT ID:** NCT03220386
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-01
- **Primary completion:** 2018-08-01
- **Final completion:** 2018-08-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2017-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03220386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03220386, "Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus (MSSA/MRSA) - Point-of-care-testing (POCT) in Clinical Decision Making". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03220386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*